CERS Cerus Corp

Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.

$4.94  -0.04 (-0.80%)
As of 07/26/2021 09:46:04 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/12/2001
Outstanding shares:  171,171,533
Average volume:  1,616,692
Market cap:   $860,992,811
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    157085101
ISIN:        US1570851014
Sedol:      2222471
Valuation   (See tab for details)
PE ratio:   -14.01
PB ratio:   9.19
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy